Insider Transactions in Q4 2021 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2021
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-13.17%
|
$90,000
$18.07 P/Share
|
|
Nov 01
2021
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-72.87%
|
$108,000
$18.07 P/Share
|
|
Oct 01
2021
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
10,000
-7.43%
|
$170,000
$17.18 P/Share
|